TRT and Liver Enzymes: What You Need to Know About Liver Health

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Testosterone replacement therapy (TRT) generally has a favorable or neutral impact on liver health, particularly with injectable or transdermal formulations. However, oral 17-alpha alkylated androgens are known to be hepatotoxic and should be avoided, while regular monitoring of liver enzymes (ALT, AST) is crucial for all men on TRT to detect any unexpected changes.

TRT and Liver Enzymes: Safeguarding Your Liver Health

For men undergoing testosterone replacement therapy (TRT), concerns about liver health and the potential for elevated liver enzymes are common. Liver enzymes, such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST), are indicators of liver function and can signal liver damage when elevated. It's important to understand that the impact of TRT on the liver is highly dependent on the formulation of testosterone used.

The Critical Distinction: Oral vs. Non-Oral Formulations

The primary concern regarding TRT and liver toxicity stems almost exclusively from oral 17-alpha alkylated androgens. These older oral testosterone derivatives were chemically modified to resist breakdown in the liver, allowing them to be absorbed intact. While effective at raising testosterone, this modification made them inherently hepatotoxic, leading to a range of liver issues including cholestasis (impaired bile flow), peliosis hepatis (blood-filled cysts in the liver), and, in rare cases, hepatic tumors (Petrovic et al., 2022). For this reason, these oral formulations are rarely, if ever, used in modern TRT protocols.

In stark contrast, contemporary TRT, primarily delivered via injectable (e.g., cypionate, enanthate), transdermal (gels, patches), or implantable pellet formulations, bypasses this initial liver metabolism. These methods deliver testosterone directly into the bloodstream, where it is metabolized in a manner similar to endogenous testosterone. Consequently, these non-oral forms of TRT are generally considered safe for the liver and are not typically associated with hepatotoxicity or significant elevations in liver enzymes (Antony et al., 2025).

TRT and Non-Alcoholic Fatty Liver Disease (NAFLD)

Interestingly, rather than causing liver damage, TRT may actually offer benefits for liver health in certain populations. Low testosterone levels are frequently observed in men with non-alcoholic fatty liver disease (NAFLD), a condition characterized by fat accumulation in the liver that can progress to more severe liver damage. Research suggests an inverse relationship between testosterone levels and NAFLD severity (Lee et al., 2024).

Several studies have indicated that TRT in hypogonadal men with NAFLD can lead to improvements in liver parameters and a reduction in hepatic steatosis (fatty liver). For example, Yassin et al. (2020) demonstrated that long-term TRT improved liver parameters and steatosis in hypogonadal men. This beneficial effect is likely mediated by testosterone's positive impact on metabolic factors such as insulin sensitivity, body composition (reducing visceral fat), and inflammation, all of which play a role in NAFLD progression.

Monitoring Liver Enzymes During TRT

Despite the general safety of modern TRT formulations, routine monitoring of liver enzymes is a prudent practice. Your doctor will typically check your ALT and AST levels:

• Baseline: Before initiating TRT, to establish your individual baseline liver function.
• Initial Follow-up: At 3 to 6 months after starting therapy, to assess for any initial changes.
• Ongoing: Annually thereafter, or more frequently if there are specific concerns or if you have pre-existing liver conditions.

While significant elevations are rare with non-oral TRT, any persistent or marked increase in liver enzymes should prompt further investigation to rule out other causes of liver dysfunction, such as viral hepatitis, alcohol-related liver disease, or other medications. Unlike the direct hepatotoxicity of oral 17-alpha alkylated androgens, any liver enzyme elevation with modern TRT is usually mild and transient, or indicative of an underlying issue unrelated to the testosterone itself.

Practical Takeaway

If you're on TRT, you'll have your liver enzymes checked periodically. Modern testosterone formulations, like injections or gels, are generally safe for your liver and don't typically cause liver damage. However, older oral testosterone pills (17-alpha alkylated androgens) are known to be toxic to the liver and are rarely prescribed today. In fact, if you have low testosterone and fatty liver disease, TRT might even improve your liver health. Always discuss any concerns about your liver enzyme results with your doctor; they'll help determine the cause of any changes and adjust your treatment plan if necessary.